Impact of Guidance on the Prescription Patterns of G-CSFs for the Prevention of Febrile Neutropenia Following Anticancer Chemotherapy: A Population-Based Utilization Study in the Lazio Region

@inproceedings{Trotta2017ImpactOG,
  title={Impact of Guidance on the Prescription Patterns of G-CSFs for the Prevention of Febrile Neutropenia Following Anticancer Chemotherapy: A Population-Based Utilization Study in the Lazio Region},
  author={Francesco Trotta and Flavia Mayer and Alessandra Mecozzi and L Santamaria Amato and Antonio Addis},
  booktitle={BioDrugs},
  year={2017}
}
Current guidelines recommend prophylaxis with granulocyte colony-stimulating factors (G-CSFs) for patients with cancer who are at greater risk of febrile neutropenia (FN) while receiving chemotherapy. G-CSF biosimilars are available and represent a savings opportunity; however, their uptake has thus far been low. Our objective was to evaluate prescribing… CONTINUE READING